India  

Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine

Video Credit: Wochit - Duration: 00:23s - Published
Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine

Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine

On Friday, shares of Novavax leaped as much as 13.3%.

It comes after Novavax finalized a deal with the UK to supply 60 million doses of its potential coronavirus vaccine.

The biotech company didn't reveal how much the UK paid for the doses.

According to a press release the UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine.


You Might Like

Related news from verified sources

Switzerland signs vaccine deal with Moderna

The Swiss federal government has struck a deal with Moderna to supply Switzerland with 4.5 million...
Hindu - Published

Serum Institute to price COVID-19 vaccine at less than Rs 250/dose

The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for...
Mid-Day - Published


Related videos from verified sources

Moderna Cuts Deal With Japan for 40M Doses of Covid-19 Vaccine [Video]

Moderna Cuts Deal With Japan for 40M Doses of Covid-19 Vaccine

Moderna will supply 40 million doses of its Covid-19 vaccine to Japan, another sign of how countries are stockpiling vaccines even before they're approved.

Credit: The Street     Duration: 02:33Published
US government wants to distribute coronavirus vaccines for free [Video]

US government wants to distribute coronavirus vaccines for free

US government wants to distribute coronavirus vaccines for free

Credit: nypost     Duration: 00:44Published
Novavax and J&J Are Getting The Royal Treatment [Video]

Novavax and J&J Are Getting The Royal Treatment

Novavax and Johnson & Johnson have a new Covid-19 customer: the U.K.,which will buy 90 million doses of their yet-to-be-proven-effective coronavirus vaccines.

Credit: The Street     Duration: 02:57Published